Douglas F Kling insider trades
Open-market stock purchases and sales by Douglas F Kling, Chief Operating Officer at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Jan 1, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NAMS NewAmsterdam Pharma Co NV: 19 sales, last Jul 16, 2025